Literatura científica selecionada sobre o tema "GlucoCEST"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "GlucoCEST".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "GlucoCEST"
Jin, Tao, Hunter Mehrens, Kristy S. Hendrich e Seong-Gi Kim. "Mapping Brain Glucose Uptake with Chemical Exchange-Sensitive Spin-Lock Magnetic Resonance Imaging". Journal of Cerebral Blood Flow & Metabolism 34, n.º 8 (28 de maio de 2014): 1402–10. http://dx.doi.org/10.1038/jcbfm.2014.97.
Texto completo da fonteBender, Benjamin, Kai Herz, Anagha Deshmane, Vivien Richter, Ghazaleh Tabatabai, Jens Schittenhelm, Marco Skardelly et al. "GLINT: GlucoCEST in neoplastic tumors at 3 T—clinical results of GlucoCEST in gliomas". Magnetic Resonance Materials in Physics, Biology and Medicine 35, n.º 1 (10 de dezembro de 2021): 77–85. http://dx.doi.org/10.1007/s10334-021-00982-5.
Texto completo da fonteKim, Mina, Afroditi Eleftheriou, Luca Ravotto, Bruno Weber, Michal Rivlin, Gil Navon, Martina Capozza et al. "What do we know about dynamic glucose-enhanced (DGE) MRI and how close is it to the clinics? Horizon 2020 GLINT consortium report". Magnetic Resonance Materials in Physics, Biology and Medicine 35, n.º 1 (15 de janeiro de 2022): 87–104. http://dx.doi.org/10.1007/s10334-021-00994-1.
Texto completo da fonteKim, Mina, Francisco Torrealdea, Sola Adeleke, Marilena Rega, Vincent Evans, Teresita Beeston, Katerina Soteriou et al. "Challenges in glucoCEST MR body imaging at 3 Tesla". Quantitative Imaging in Medicine and Surgery 9, n.º 10 (outubro de 2019): 1628–40. http://dx.doi.org/10.21037/qims.2019.10.05.
Texto completo da fonteNasrallah, Fatima A., Guilhem Pagès, Philip W. Kuchel, Xavier Golay e Kai-Hsiang Chuang. "Imaging Brain Deoxyglucose Uptake and Metabolism by Glucocest MRI". Journal of Cerebral Blood Flow & Metabolism 33, n.º 8 (15 de maio de 2013): 1270–78. http://dx.doi.org/10.1038/jcbfm.2013.79.
Texto completo da fonteKentrup, Dominik, Annika Busch, Helga Pawelski, Eberhard Schlatter, Verena Hoerr e Stefan Reuter. "SP772NON-INVASIVE DETECTION OF ACUTE RENAL ALLOGRAFT REJECTION THROUGH GLUCOCEST MRI". Nephrology Dialysis Transplantation 30, suppl_3 (maio de 2015): iii632. http://dx.doi.org/10.1093/ndt/gfv201.05.
Texto completo da fonteColgan, Niall, Matthew Donoghue, Zdzislaw Zuchora, Brendan Tuohy e Wil van der Putten. "Investigation of GlucoCEST as novel clinical MR biomarker of glucose metabolism". Physica Medica 32, n.º 7 (julho de 2016): 959. http://dx.doi.org/10.1016/j.ejmp.2016.05.048.
Texto completo da fonteXu, Xiang, Jiadi Xu, Kannie W. Y. Chan, Jing Liu, Huanling Liu, Yuguo Li, Lin Chen, Guanshu Liu e Peter C. M. van Zijl. "GlucoCEST imaging with on-resonance variable delay multiple pulse (onVDMP) MRI". Magnetic Resonance in Medicine 81, n.º 1 (29 de julho de 2018): 47–56. http://dx.doi.org/10.1002/mrm.27364.
Texto completo da fonteKentrup, Dominik, Philipp Bovenkamp, Annika Busch, Katharina Schuette-Nuetgen, Helga Pawelski, Hermann Pavenstädt, Eberhard Schlatter et al. "GlucoCEST magnetic resonance imaging in vivo may be diagnostic of acute renal allograft rejection". Kidney International 92, n.º 3 (setembro de 2017): 757–64. http://dx.doi.org/10.1016/j.kint.2017.04.015.
Texto completo da fonteXu, Xiang, Jiadi Xu, Linda Knutsson, Jing Liu, Huanling Liu, Yuguo Li, Bachchu Lal et al. "The effect of the mTOR inhibitor rapamycin on glucoCEST signal in a preclinical model of glioblastoma". Magnetic Resonance in Medicine 81, n.º 6 (22 de fevereiro de 2019): 3798–807. http://dx.doi.org/10.1002/mrm.27683.
Texto completo da fonteTeses / dissertações sobre o assunto "GlucoCEST"
Delebarre, Thaddée. "Development of fast and robust metabolic imaging in humans at high magnetic field". Electronic Thesis or Diss., université Paris-Saclay, 2024. http://www.theses.fr/2024UPAST001.
Texto completo da fonteChemical Exchange Saturation Transfer Magnetic Resonance Imaging (CEST MRI) represents a powerful tool for the study of metabolism, offering superior temporal and spatial resolution as well as increased sensitivity compared to Magnetic Resonance Spectroscopy (MRS). CEST MRI enables the indirect detection of certain metabolites through the interaction between their labile protons and those of bulk water. CEST can map glucose, glutamate, creatine, which are important metabolites involved in cancers, and neurodegenerative and musculoskeletal diseases, representing therefore a promising bioimaging tool. The rapid development of high magnetic field MRI ((≥7 T) in recent decades greatly benefits CEST, opening up new applications and generating growing interest.The aim of this thesis is to develop CEST MRI in a clinical context, taking full advantage of high magnetic fields to increase the robustness and speed of CEST acquisitions. To this end, we focus on two main objectives. The first is to develop the CEST imaging method in a clinical environment, overcoming the practical limitations associated with high-field clinical MRI scanners, notably the strict constraints of Specific Absorption Rate (SAR) and RadioFrequency (RF) field heterogeneities (B1).To achieve this first objective, a parallel transmission CEST sequence was developed. Parallel transmission uses a multi-channel RF transmit antenna, which can be controlled independently to reduce B1 heterogeneity. Moreover, parallel transmission also allows optimized energy management using virtual observation points (a strategy developed in the laboratory) By making use of parallel transmission we have implemented an acquisition strategy which allowed us to produce CEST images with three times less B1 heterogeneity, and two times faster than compared to the state of the art literature reports.The second objective is to evaluate the performance of CEST, glucose, and glutamate weighted, in detecting and characterizing normal and pathological aging. A clinical study was carried out, involving young and elderly healthy volunteers as well as Alzheimer’s disease (AD) patients. The results showed that CEST can detect global variations in glutamate and glucose in the brain associated with aging. The acquisition and exploitation of data from AD patients is still in progress.In conclusion, this thesis has enabled the development of high-field CEST methods and the evaluation of their performance in the study of aging. These results open up encouraging prospects for the use of CEST as a biomarker of AD and other neurodegenerative diseases
Livros sobre o assunto "GlucoCEST"
Hogg e European Society Of Pneumology. Glucocort Inflam Bronch Hyper: (Current Clinical Practice). Elsevier Science & Technology, 1985.
Encontre o texto completo da fonteCapítulos de livros sobre o assunto "GlucoCEST"
Torrealdea, Francisco, Marilena Rega e Xavier Golay. "Chapter 17 GlucoCEST: Imaging Glucose in Tumors". In Chemical Exchange Saturation Transfer Imaging, 399–426. Penthouse Level, Suntec Tower 3, 8 Temasek Boulevard, Singapore 038988: Pan Stanford Publishing, 2017. http://dx.doi.org/10.1201/9781315364421-18.
Texto completo da fonte